The Performance of Second-line Integrated Molecular Profiling Compared to Common, First-line Testing Risk Features in Diagnosing and Predicting Benign and Malignant Pancreatic Lesions: Interim Results from an Outcome-based Registry in 422 Patients

被引：0

作者：

Al-Haddad, Mohammad ^{[1
]}

Schmidt, Christian ^{[1
]}

Catalano, Marc ^{[2
]}

Haddad, Nadim ^{[3
]}

Malhotra, Nidhi ^{[3
]}

Mertz, Howard ^{[4
]}

Siddiqui, Ali ^{[5
]}

Kowalski, Thomas ^{[5
]}

Patel, Sandeep ^{[6
]}

Okoh, Emuejevoke ^{[6
]}

Lybik, Mark ^{[7
]}

Mallat, Damien ^{[8
]}

Karasik, Michael ^{[9
]}

Swales, Colin ^{[9
]}

Linder, Jeffrey ^{[10
]}

Corcoran, Brendan ^{[11
]}

Ellsworth, Eric ^{[11
]}

Jackson, Sara ^{[11
]}

Finkelstein, Sydney ^{[11
]}

机构：

[1] Indiana Univ, Indianapolis, IN 46204 USA

[2] St Lukes Med Ctr, Milwaukee, WI USA

[3] Georgetown Univ, Washington, DC USA

[4] Nashville GI Associates, Nashville, TN USA

[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[6] Univ Texas San Antonio, San Antonio, TX USA

[7] Northside Gastroenterol, Indianapolis, IN USA

[8] Premier Gastroenterol Texas, Dallas, TX USA

[9] Connecticut GI PC, Hartford, CT USA

[10] Digest Hlth Associates Texas, Dallas, TX USA

[11] RedPath Integrated Pathol, Pittsburgh, PA USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷

关键词：

D O I：

10.14309/00000434-201310001-00199

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

199

引用

页码：S62 / S63

页数：2